Long-term outcomes of adult cryptogenic febrile infection-related epilepsy syndrome (FIRES)

被引:4
作者
Shi, Xiaojing [1 ]
Wang, Yuanyuan [1 ]
Wang, Xuan [1 ]
Kang, Xiaogang [1 ]
Yang, Fang [1 ]
Yuan, Fang [2 ]
Jiang, Wen [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian, Peoples R China
[2] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Neurol, Guangzhou, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2023年 / 13卷
基金
中国国家自然科学基金;
关键词
febrile infection-related epilepsy syndrome; adult; new-onset refractory status epilepticus; refractory status epilepticus; long-term outcome; case series; REFRACTORY STATUS EPILEPTICUS; EFNS GUIDELINE; MANAGEMENT;
D O I
10.3389/fneur.2022.1081388
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundCryptogenic febrile infection-related epilepsy syndrome (FIRES) is a rare but catastrophic encephalopathic condition. We aimed to investigate the long-term outcome in adult cryptogenic FIRES. MethodsThis was a retrospective study based on the prospective database in the neuro-intensive care unit of a tertiary hospital in China. Consecutive adult patients with cryptogenic FIRES between July 2007 to December 2021 were included. Long-term outcomes included function independence, the development of drug-resistant epilepsy (DRE), remote recurrent status epilepticus (SE), anti-seizure medications (ASMs), and changes in the brain Magnetic Resonance Imaging (MRI). ResultsA total of 11 adult patients with cryptogenic FIRES were identified from 270 patients with SE. Four (36%) patients died in the hospital, with three of them withdrawing treatments, and one patient died 12 months after discharge. After the follow-up ranging from 12 to 112 months, 6 (55%) patients were still alive, and all of them achieved functional independence [modified Rankin Scale (mRS) 0-3]. 45% (5/11) patients developed DRE, 18% (2/11) had remote recurrent SE, and 55% (6/11) were on polytherapy with ASMs at the last follow-up. Most of the patients with initial normal or abnormal MRI had abnormalities in the hippocampus at follow-up, and most of the other MRI abnormalities found in the acute stage disappeared over time. ConclusionThe outcome of adult cryptogenic FIRES is daunting. More than one-third of patients die in the hospital. Survivors of cryptogenic FIRES may regain functional independence, but they usually develop DRE and receive polytherapy of ASMs for a long time.
引用
收藏
页数:8
相关论文
共 33 条
  • [1] A case of febrile infection-related epilepsy syndrome (FIRES) in young adult: still a diagnostic and therapeutic challenge
    Acampora, Roberto
    Quiroga Subirana, Pablo
    Durante, Luana
    Tonziello, Rossella
    Aversano, Giuseppina
    Lieto, Maria
    Ripa, Patrizia
    Mazzaferro, Maria Pia
    [J]. NEUROLOGICAL SCIENCES, 2022, 43 (07) : 4555 - 4558
  • [2] Unified EEG terminology and criteria for nonconvulsive status epilepticus
    Beniczky, Sandor
    Hirsch, Lawrence J.
    Kaplan, Peter W.
    Pressler, Ronit
    Bauer, Gerhard
    Aurlien, Harald
    Brogger, Jan C.
    Trinka, Eugen
    [J]. EPILEPSIA, 2013, 54 : 28 - 29
  • [3] Guidelines for the Evaluation and Management of Status Epilepticus
    Brophy, Gretchen M.
    Bell, Rodney
    Claassen, Jan
    Alldredge, Brian
    Bleck, Thomas P.
    Glauser, Tracy
    LaRoche, Suzette M.
    Riviello, James J., Jr.
    Shutter, Lori
    Sperling, Michael R.
    Treiman, David M.
    Vespa, Paul M.
    [J]. NEUROCRITICAL CARE, 2012, 17 (01) : 3 - 23
  • [4] Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome
    Clarkson, Benjamin D. S.
    LaFrance-Corey, Reghann G.
    Kahoud, Robert J.
    Farias-Moeller, Raquel
    Payne, Eric T.
    Howe, Charles L.
    [J]. ANNALS OF NEUROLOGY, 2019, 85 (04) : 526 - 537
  • [5] The spectrum of neuroimaging findings in febrile infection-related epilepsy syndrome (FIRES): A literature review
    Culleton, Sinead
    Talenti, Giacomo
    Kaliakatsos, Marios
    Pujar, Suresh
    D'Arco, Felice
    [J]. EPILEPSIA, 2019, 60 (04) : 585 - 592
  • [6] Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome
    Dilena, Robertino
    Mauri, Eleonora
    Aronica, Eleonora
    Bernasconi, Pia
    Bana, Cristina
    Cappelletti, Cristina
    Carrabba, Giorgio
    Ferrero, Stefano
    Giorda, Roberto
    Guez, Sophie
    Catenacci, Stefano Scalia
    Triulzi, Fabio
    Barbieri, Sergio
    Calderini, Edoardo
    Vezzani, Annamaria
    [J]. EPILEPSIA OPEN, 2019, 4 (02) : 344 - 350
  • [7] Febrile infection-related epilepsy syndrome (FIRES) in an adult patient: an early neuroradiological finding
    Fatuzzo, Daniela
    Giuliano, Loretta
    Mainieri, Greta
    Sortino, Giuseppe
    Sofia, Vito
    Zappia, Mario
    [J]. NEUROLOGICAL SCIENCES, 2019, 40 (11) : 2407 - 2410
  • [8] New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives
    Gaspard, Nicolas
    Hirsch, Lawrence J.
    Sculier, Claudine
    Loddenkemper, Tobias
    van Baalen, Andreas
    Lancrenon, Judette
    Emmery, Michel
    Specchio, Nicola
    Farias-Moeller, Raquel
    Wong, Nora
    Nabbout, Rima
    [J]. EPILEPSIA, 2018, 59 (04) : 745 - 752
  • [9] New-onset refractory status epilepticus
    Gaspard, Nicolas
    Foreman, Brandon P.
    Alvarez, Vincent
    Kang, Christian Cabrera
    Probasco, John C.
    Jongeling, Amy C.
    Meyers, Emma
    Espinera, Alyssa
    Haas, Kevin F.
    Schmitt, Sarah E.
    Gerard, Elizabeth E.
    Gofton, Teneille
    Kaplan, Peter W.
    Lee, Jong W.
    Legros, Benjamin
    Szaflarski, Jerzy P.
    Westover, Brandon M.
    LaRoche, Suzette M.
    Hirsch, Lawrence J.
    [J]. NEUROLOGY, 2015, 85 (18) : 1604 - 1613
  • [10] Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases
    Gofshteyn, Jacqueline S.
    Wilfong, Angus
    Devinsky, Orrin
    Bluvstein, Judith
    Charuta, Joshi
    Ciliberto, Michael A.
    Laux, Linda
    Marsh, Eric D.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2017, 32 (01) : 35 - 40